vaccines
| 6 min read
A century after the first vaccine, tuberculosis still claims over a million lives a year, but promising research could change the story.
| 6 min read
Harnessing human-first models to accelerate drug discovery, improve safety, and capture the diversity of human biology.
| 2 min read
Trinity College Dublin researchers report a nasal vaccine that prevented infection and spread of pertussis in preclinical models.
Available on Demand
Explore innovative methods to enhance RNA purification efficiency and ensure scalable, high-quality RNA production.
| 4 min read
Two new FDA approvals and promising clinical trial results for drugs to treat diabetes and lung cancer, and more led the news this week.
| 4 min read
The Bethesda Declaration, a new RSV antibody for kids, amylin’s promising weight loss results, and more were industry’s need-to-know stories this week.
| 4 min read
HHS decisions on COVID-19 and flu vaccines, new therapies with encouraging results for depression and ALS, and more industry news this week.
| 3 min read
Vaxart’s orally administered vaccine tablet was safe and elicited mucosal immunity in older adults.
| 4 min read
A landmark UTI drug approval, new hope for the amyloid hypothesis in Alzheimer’s disease, a brewing vaccine study controversy, and more led the news this week.
| 4 min read
Merck researchers developed an effective vaccine against pneumococcal diseases.
